dual orexin receptor antagonist investigated treatment insomnia human trials produced dosedependent sedative effects generally well tolerated residual sleepiness headache common adverse humans sedative effects began minutes oral administration dissipated within hours consistent favorable pharmacodynamic profile treatment insomnia however pharmacokinetic profile diverges significantly would expected based behavioral effects elevated plasma concentrations sustained hours administration despite behavioral measures sedation disappearing within hours sedativerelated article stub help wikipedia expanding drug article relating nervous system stub help wikipedia expanding